![Pei Lan Chu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pei Lan Chu
Directeur Financier/CFO chez
SYNERGY SCIENTECH CORP.
Profil
Pei Lan Chu is currently the Chief Financial Officer & Deputy General Manager at SYNergy ScienTech Corp.
Prior to this, he worked as the Investment Relations Officer at Tanvex BioPharma, Inc. from 2015 to 2019.
Before that, he was the Director-Biotech Section at President International Development Corp.
Mr. Chu holds an MBA from National Sun Yat-Sen University.
Postes actifs de Pei Lan Chu
| Sociétés | Poste | Début |
|---|---|---|
| SYNERGY SCIENTECH CORP. | Directeur Financier/CFO | 01/07/2019 |
Anciens postes connus de Pei Lan Chu
| Sociétés | Poste | Fin |
|---|---|---|
| TANVEX BIOPHARMA, INC. | Investor Relations Contact | - |
President International Development Corp.
 President International Development Corp. Financial ConglomeratesFinance manages investments and provides financial consulting services | Corporate Officer/Principal | - |
Formation de Pei Lan Chu
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
15
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
National Sun Yat-Sen University
 National Sun Yat-Sen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SYNergy ScienTech Corp.
 SYNergy ScienTech Corp. Electrical ProductsProducer Manufacturing Manufactures rechargeable lithium-ion and lithium-ion polymer batteries | Producer Manufacturing |
President International Development Corp.
President International Development Corp. Financial ConglomeratesFinance manages investments and provides financial consulting services | Finance |
Tanvex BioPharma, Inc.
 Tanvex BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures biosimilar medicines to treat neutropenia, breast cancer and metastatic colorectal cancer | Health Technology |
Choisissez Zonebourse 
